Business news

NEW DELHI, 11 September (BelTA) – Belarusian-Indian pharmaceutical companies in Belarus will make more components locally, BelTA learned from Belarusian Healthcare Minister Valery Malashko.

The official said that India is Belarus’ strategic partner in pharmaceutics. “We buy over 250 substances from Indian companies. Accomplishments of the Belarusian pharmaceutical industry are known well, yet it is necessary to reach new standards, new medications, and technologies. Contracts have been signed with the companies leading in new medications and nanotechnologies. These companies have agreed to work with us. We will get totally new quality of medications,” said Valery Malashko.

The healthcare minister noted that three investment projects are already being implemented in Belarus. Those are manufacturing facilities in Skidel, Kolodishchi, and Beshenkovichi.

Several Belarusian-Indian pharmaceutical enterprises will be commissioned in Belarus in 2017-2018 to make medications to treat cancer, tuberculosis, HIV, hepatitis, antitumor medications, and monoclonal antibodies. “We will start making these medications in Belarus with consequent more profound localization,” stated the healthcare minister.

In his words, the Belarusian delegation also includes scientists, who intend to visit pharmaceutical companies, including research labs. “I have no doubt that we will find areas we will be able to jointly explore,” said Valery Malashko.

BelTA reported earlier that a number of agreements and memorandums were signed during the Belarusian-Indian business forum in New Delhi. The number includes a general agreement on strategic partnership between the Belarusian Healthcare Ministry and Hetero Labs Company Limited, a trilateral term sheet between the Healthcare Ministry, Glorincor Company, and Biocon Limited Company, and a trilateral term sheet between the Healthcare Ministry, Glorincor Company, and Cadila Healthcare Limited Company.